Oral N-acetylglucosamine in Crohn's Disease | MicrobiomeTrials← Back to trialsNCT07225998
Oral N-acetylglucosamine in Crohn's Disease
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-11-01Est. Completion: 2028-07-31
Enrollment target: 40 participants Locations- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Crohn's Disease
This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evalu…
Sun City, United StatesEst. completion Jul 30, 2026
Fibrostenotic Crohn's Disease
This is an open, two-part study in healthy male volunteers, aged 30-65 years.
This trial aims to understand how the hum…
Nottingham, United KingdomEst. completion Sep 26, 2026